← Back to Search

Procedure

Disposable Flexible Ureteroscope and Flexible Digital Ureteroscope for Kidney Stones

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a single-use flexible ureteroscope for patients needing urinary tract examination. It aims to reduce costs and infection risks associated with reusable devices by using a disposable one. LithoVue was the first widely adopted single-use flexible ureteroscope.

Eligible Conditions
  • Kidney Stones
  • Urinary Tract Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Scope performance
Secondary study objectives
Operating room outcomes
Post-operative outcomes
Post-operative surgery satisfaction of the flexible utereoscope using a questionnaire: color interference
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Storz Flex-XC1 disposable flexible ureteroscopeExperimental Treatment1 Intervention
A patient is randomized to the experimental arm using the Storz Flex-XC1 disposable flexible ureteroscope.
Group II: Digital ureteroscopeExperimental Treatment1 Intervention
A patient is randomized to the experimental arm using a Digital ureteroscope.
Group III: Analogue scopeActive Control1 Intervention
A patient is not randomized to the experimental arm using the Storz Flex-XC1 disposable flexible ureteroscope.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Storz Flex-XC1 Disposable Flexible Ureteroscope
2022
N/A
~10
Storz Flexible Digital Ureteroscope
2022
N/A
~10

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,645 Previous Clinical Trials
958,588 Total Patients Enrolled
5 Trials studying Kidney Stones
604 Patients Enrolled for Kidney Stones

Media Library

Storz Flexible Digital Ureteroscope (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05646069 — N/A
Kidney Stones Research Study Groups: Analogue scope, Storz Flex-XC1 disposable flexible ureteroscope, Digital ureteroscope
Kidney Stones Clinical Trial 2023: Storz Flexible Digital Ureteroscope Highlights & Side Effects. Trial Name: NCT05646069 — N/A
Storz Flexible Digital Ureteroscope (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05646069 — N/A
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top